BlueOcean
BlueOcean (BOV)
More on ICO
Token Sale Oct. 15, 2018 - Dec. 21, 2018
ICOMarks Rating 4.4 / 10
Whitelist/KYC Whitelist & KYC
Token price Unspecified
Platform Ethereum

BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field. For the first time, the BlueOcean STO gives investors the possibility of buying a tradable token (BOV Token) in the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments. 5 Existing portfolio companies, This STO will allow investing in more startups in order to reach a portfolio size of 8 to 12.

Team members

Emmanuel de Watteville
General Partner and Co-Founder
Thomas Zehnder
General Partner
Jean-Etienne Durand
Head of Operations
Lug Giroud
Head of Marketing
Christophe Saam
Swiss & European Patent Attorney
Olivier Crochat
STO Technology Advisor

ICO Advisors

Antonio Gambardella
Advisor
2008

Launch of BlueOcean Ventures I

2015

Launch of the second fund, BlueOcean Ventures II

2016

BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA

2017

BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)

MAY 2018

Set up of Special STO Investment Vehicle in Singapore

JULY 2018

BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO

DECEMBER 2018

End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II

BEGINNING OF 2019

BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups

2020/2021

BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company

2025

BlueOcean Ventures II is closed, all remaining assets are distributed to the investors